Flow Mediated Dilatation in People with Type 2 Diabetes and Cardiovascular Disease - 11/08/11
Doi : 10.1016/j.hlc.2010.06.586
M. Mohamed 1, 4, ⁎, I. Levinger 1, D. Toia 2, D.L. Hare 2, G. Jerums 3, S. Selig 1
1 Institute of Sport, Exercise and Active Living (ISEAL), School of Sport and Exercise Science, Victoria University, Australia
2 Department of Cardiology Austin Health, University of Melbourne, Australia
3 Department of Endocrinology Austin Health, University of Melbourne, Australia
4 Sports Medicine Unit, Medical Faculty, University of Malaya, Kuala Lumpur, Malaysia
Corresponding author.
Il testo completo di questo articolo è disponibile in PDF.
© 2010
Pubblicato da Elsevier Masson SAS.
Vol 19 - N° S2
P. S241-S242 - 2010 Ritorno al numero
Articolo precedente
- Early Effectiveness and Safety Results from the CoreValve Transcatheter Aortic Valve Australia–New Zealand Study
- J. Ormiston, I. Meredith, D. Walters, T. Walton, S. Pasupati, D. Muller, S. Worthley, G. Yong, R. Whitbourn
- Group Cognitive Behaviour Therapy for Cardiac Patients: Results of a Randomised Controlled Trial
- B. Murphy, R. Higgins, M. Worcester, P. Elliott, H. Navaratnam, F. Mitchell, M. Le Grande, A. Goble
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?